Synoviolin Antibodies

Santa Cruz Biotechnology delivers a wide array of Synoviolin Antibodies for research focused on understanding synoviolin's role in various biological processes. Synoviolin Antibodies are validated for techniques including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Synoviolin, also known as HRD1, is an E3 ubiquitin ligase essential for regulating protein degradation and cellular homeostasis. Research has shown synoviolin's significance in synovial tissue, where it influences the development of rheumatoid arthritis and other inflammatory conditions. Through modulation of misfolded protein degradation, synoviolin maintains cellular function and prevents stress-induced apoptosis. Understanding synoviolin's mechanisms can lead to breakthroughs in treating inflammatory disorders and cellular stress-related conditions. Research utilizing synoviolin monoclonal antibodies has revealed important insights about protein quality control and cellular stress responses. Investigating synoviolin's role in disease progression may uncover new therapeutic approaches for inflammatory and degenerative conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of synoviolin's biological functions and therapeutic potential.